Aspire Biopharma Holdings in (ASBP)

CUSIP: 738920305 | NYSE | 13 institutional holders

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13GFunk, Stephen P. with Alta Investments LLC	91,570	5.8%	New 5%+ stake	Oct 6, 2026	No 13F filer matched
13G/ALance Friedman	107,323	7.9%	New 5%+ stake

Institutional Holders — Q3 2026

Sort by

FNY Investment Advisers, LLC27,759

0.0% of portfolio$231

Geode Capital Management, LLC16,025

0.0% of portfolio$133.8K

UBS Group AG1

0.0% of portfolio$8

				Style	Turnover	Location	Filed
FNY Investment Advisers, LLC	27,759	$231	0.0%	Growth	Very High	New York, NY	2026-10-16
Geode Capital Management, LLC	16,025	$133.8K	0.0%	Index	Very Low	Boston, MA	2026-11-06
UBS Group AG	1	$8	0.0%	Core	Medium	Zurich, Switzerland	2026-11-10

13GFunk, Stephen P.91,570

5.8% of class · Oct 6, 2026New 5%+ stake

with Alta Investments LLC

No 13F filer matched

13G/ALance Friedman107,323

7.9% of class · Aug 4, 2026New 5%+ stake

No 13F filer matched

13G/A Highbridge Capital Management LLC78

0.0% of class · Jun 30, 2026Newly reported

Not yet in a 13F

13GRubenbauer Alois Ryan III65,000

5.0% of class · Jun 25, 2026New 5%+ stake

No 13F filer matched

13GGary Shirinyan99,900

7.7% of class · Jun 17, 2026New 5%+ stake

No 13F filer matched